BCAX NASDAQ

Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Bicara Therapeutics Inc. Common Stock would be worth roughly what it owes.
Total debt $1.2M against a stock market value of $1.16B.
Distance to default 12.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.2M (short-term plus half of long-term), stock volatility 54.2%; Altman Z'' 11.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.